Immunosuppression by D-isomers of HLA class I heavy chain (amino acid 75 to 84)-derived peptides is independent of binding to HSC70

Transplantation

Volumn 64, Issue 10, 1997, Pages 1460-1467

  Woo, Jacky ^a   Iyer, Suhasini ^a   Cornejo, Marie Christine ^a   Gao, Lan ^a   Cuturi, Cristina ^b   Soulillou, Jean Paul ^b   Buelow, Roland ^a  

^a GENZYME CORPORATION   (United States)

^b NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; HEAT SHOCK PROTEIN 70; HLA ANTIGEN CLASS 1; VALINE;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GRAFT SURVIVAL; HEART TRANSPLANTATION; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOMODULATION; LYMPHOKINE ACTIVATED KILLER CELL; MOUSE; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL;

EID: 0030780598     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199711270-00015     Document Type: Article

References (63)

1. Grumet CF, Buelow R, Grosse-Wilde H, Kubens B, Garovoy M, Pouletty P. Report of the Second International Soluble (sHLA) Workshop. Human Immunol 1994; 40: 153.
2. Buelow R, Burlingham WJ, Clayberger C. Immunomodulation by soluble HLA class I. Transplantation 1995; 59: 649.
3. Zavazava N, Kronke M. Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nature Med 1996; 2: 1005.
4. Foster S, Wood KUJ, Morris PJ. The effectiveness of pretreatment with soluble or membrane-bound donor class I major histocompatibility complex antigens in the induction of unresponsiveness to a subsequent rat renal allograft. Transplantation 1992; 53: 1322.
5. Sumimoto R, Kamada N. Evidence that soluble class I antigen in donor serum induces the suppression of heart allograft rejection in rats. Immunol Lett 1990; 26: 81.
6. Priestley CA, Dalchau R, Sawyer GJ, Fabre JW. A detailed analysis of the potential of water soluble class I molecules for the suppression of kidney allograft rejection and in vitro cytotoxic T cell responses. Transplantation 1989; 48: 1031.
7. Spencer SC, Fabre JW. Bulk purification of a naturally occurring soluble form of RTI-A class I major histocompatibility complex antigens from DA rat liver, and studies of specific immunosuppression. Transplantation 1987; 44: 141.
8. Clayberger C, Lyu SC, Pouletty P, Krensky AM. Peptides corresponding to T-cell receptor-HLA contact regions inhibit class I-restricted immune responses. Transplant Proc 1993; 25: 477.
9. Nisco S, Vriens P, Hoyt G, et al. Induction of allograft tolerance in rats by an HLA class-I-derived peptide and cyclosporine A. J Immunol 1994; 152: 3786.
10. Buelow R, Veyron P, Clayberger C, Pouletty P, Touraine JL. Prolongation of skin allograft survival in mice following administration of Allotrap. Transplantation 1995; 59: 455.
11. Cuturi MC, Josien R, Douillard P, et al. Prolongation of allogeneic heart graft survival in rats by administration of a peptide (a.a. 75-84) from the al helix of the first domain of HLA-B701. Transplantation 1995; 59: 661.
12. Woo J, Gao L, Cornejo MC, Buelow R. A synthetic dimeric HLA class I peptide inhibits T cell activity in vitro and prolongs allogeneic heart graft survival in a mouse model. Transplantation 1995; 60: 1156.
13. Gao L, Woo J, Buelow R. Both L- and D-isomers of HLA class I heavy chain derived peptides prolong heart allograft survival in mice. Heart Lung Transplant 1996; 15: 78.
14. Hanaway M, Geissler E, Wang J, Fechner J, Buelow R, Knechtle S. Immunosuppressive effects of an HLA class I-derived peptide in a rat cardiac allograft model. Transplantation 1996; 61: 1222.
15. Giral M, Cuturi MC, Nguyen JM, et al. Decreased cytotoxic activity of natural killer cells in kidney allograft recipients treated with human HLA-derived peptide. Transplantation 1997; 63: 1004.
16. Noessner E, Goldberg JE, Naftzger C, Lyu SC, Clayberger C, Krensky AM. HLA-derived peptides which inhibit T-cell function bind to members of the heat shock protein 70 family. J Exp Med 1996; 183: 339.
17. Ellis RJ, van der Vies SM. Molecular chaperones. Annu Rev Biochem 1991; 60: 321.
18. Georgopoulos C, Welch WJ. Role of major heat shock proteins as molecular chaperones. Annu Rev Cell Biol 1993; 9: 601.
19. Gething MJ, Sambrook J. Protein folding in the cell. Nature 1992; 355: 33.
20. Morimoto RI, Tissieres A, Georgopoulos C. The biology of heat shock proteins and molecular chaperones. Cold Spring Harbor Monograph Series. Plain View, NY: Cold Spring Harbor Laboratory, 1994.
21. De Nagel DD, Pierce SK. Heat shock proteins in immune responses. Crit Rev Immunol 1993; 13: 71.
22. Perdrizet GA. The heat shock response and organ transplantation. Transplantation Rev 1996; 10(2): 78.
23. Hutchinson KA, Dittmar KD, Pratt WB. All of the factors required for assembly of the glucocorticoid receptor into a functional heterocomplex with heat shock protein 90 are preassociated in a self-sufficient protein folding structure, a "foldosome". J Biol Chem 1994; 269(45): 27894.
24. Srivastava PK. Peptide-binding heat shock proteins in the endoplasmic reticulum: role in immune response to cancer and in antigen presentation. Adv Cancer Res 1993; 62: 153.
25. Suto R, Srivastava PK. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 1995; 269: 1588.
26. Polla B, Mariethoz E. More evidence for a case of chaperones in antigen processing. Immunol Today 1992; 13: 421.
27. William DB, Watts TH. Molecular chaperones in antigen presentation. Curr Opin Immunol 1995; 7: 77.
28. Duquesnoy RJ, Liu K, Moliterno RA, Attfield D. Do heat shock proteins play a role in transplant immunity. Transplantation Rev 1996; 10(3): 175.
29. Zemmour J, Parham P. HLA class I nucleotide sequences. Immunogenetics 1992; 37: 239.
30. Koller BH, Geraghty DE, Shimizu Y, DeMars R, Orr HT. A novel HLA class I gene expressed in resting T lymphocytes. J Immunol 1988; 141: 897.
31. Heinrichs H, Orr HT. HLA non-A,B,C class I genes: their structure and expression. Immunol Res 1990; 9(4): 265.
32. Minamide LS, Callahan GN, Grosveld FG, Hui KM. The nucleotide sequence of the H-2K gene of CSHf/HeN mice. Immunogenetics 1988; 27: 148.
33. Watts S, Vogel JM, Harriman WD, Itoh T, Strauss HJ, Goodenow RS. DNA sequence analysis of the C3H H-2K-k and H-2D-k loci: evolutionary relationships to the H-2 genes from four other mouse strains. J Immunol 1987; 139: 3878.
34. Reyes AA, Schoeld M, Itakura K, Wallace RB. Isolation of a cDNA clone for the murine transplantation antigen H-2K-b. Proc Natl Acad Sc USA 1982; 79: 3270.
35. + T cell and B cell responses after cardiac allograft rejection. Transplantation 1995; 59: 401.
36. Farrar JJ, Fuller-Farrar J, Simon PL, Hunker ML, Stadler BM, Farrar WL. Thymoma production of T cell growth factor (interleukin 2). J Immunol 1980; 125(6): 2555.
37. Chock SP, Eisenber E. The mechanism of the skeletal myosin ATPase. J Biol Chem 1979; 54(9): 3229.
38. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 7: 225.
39. Fourie AM, Sambrook JF, Gething MJH. Common and divergent peptide binding specificities of hsp molecular chaperones. J Biol Chem 1994; 269(48): 30470.
40. Schneck J, Maloy WL, Coligan JE, Margulies DH. Inhibition of an allospecific T cell hybridoma by soluble class I proteins and peptides: estimation of the affinity of a T cell receptor for MHC. Cell 1989; 56: 47.
41. Parham P, Clayberger C, Zorn SL, Ludwig DS, Schoolnik GK, Krensky AM. Inhibition of alloreactive cytotoxic T lymphocytes by peptides from the alpha 2 domain of HLA-A2. Nature 1987; 325: 625.
42. Olson CA, Williams LC, McLaughlin-Taylor E, McMillan M. Creation of H-2 class I epitopes using synthetic peptides: recognition of alloreactive cytotoxic T lymphocytes. Proc Natl Acad Sci USA 1989; 86: 1031.
43. Moretta A, Bottino C, Vitale M, et al. Receptors for HLA-class I molecules in human natural killer cells. Annu Rev Immunol 1996; 14: 619.
44. Shokes DA, Wood KJ. Indirect presentation of MHC antigens in transplantation. Immunol Today 1994; 15: 32.
45. Sayegh MH, Watschinger B, Carpenter CB. Mechanism of T cell recognition of alloantigen: the role of peptides. Transplantation 1994; 57: 1295.
46. Benham AM, Sawjer GJ, Fahre JW. Indirect T cell allorecognition of donor antigens contributes to the rejection of vascularized kidney allografts. Transplantation 1995; 59: 1028.
47. Denner J. Immunosuppression by oncogenic retroviriday. In: Zschiesche W, ed. Modulation of the immune response by infectious agents. Jena, Germany: Fischer, 1987: 114.
48. Gao B, Eisenberg E., Green L. Interaction of nucleotide-free Hsc70 with clathrin and peptide and effect of ATP analogues. Biochemistry 1995; 34(37): 11882.
49. Schlossman DM, Schmid SL, Braell WA, Rothman JE. An enzyme that removes clathrin coats: purification of an uncoating ATPase. J Cell Biol 1984; 99: 723.
50. Takenaka IM, Leung SM, McAndrew SJ, Brown JP, Hightower LE. Hsc-70-binding peptides selected from a phage display library resemble organellar targeting sequences. J Biol Chem 1995; 270(34): 19839.
51. Zhu X, Zhao X, Burkholder WF, et al. Structural analysis of substrate binding by the molecular chaperone DnaK. Science 1996; 272: 1606.
52. Hightower LE, Sadis SE. Interactions of vertebrate hsc70 and hsp70 with unfolded proteins and peptides. In: Morimoto RI, Tissieres A, Georgopoulos C, eds. The biology of heat shock proteins and molecular chaperones. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1994: 179.
53. Zawadzke LE, Berg JM. A racemic protein. J Am Chem Soc 1992; 114: 4002.
54. Guichard G, Benkirane N, Zeder-Lutz G, Van Regenmortel MHV, Briand JP, Muller S. Antigenic mimicry of natural L-peptides with retro-inverse peptidomimetics. Proc Natl Acad Sci USA 1994; 91: 9765.
55. Gill TJ, Gould HJ, Doty P. Role of optical isomers in determining the antigenicity of synthetic polypeptides. Nature 1963; 197; 746.
56. Maurer PH. Antigenicity of polypeptides (poly-alpha amino acids). X. Studies with polymers of D-amino acids. Proc Soc Exp Biol 1963; 113: 553.
57. Maurer PH. Antigenicity of polypeptides (poly-alpha amino acids). XIII. Immunological studies with synthetic polymers containing only D- or D- and L-a-amino acids. J Exp Med 1965; 121: 339.
58. Borek F, Stupp Y, Fuchs S, Sela M. Relation between optical configuration and immunogenicity of polypeptides. Biochem J 1965; 96: 577.
59. Ben-Efraim S, Fuchs S, Sela M. Differences in immune response to synthetic antigens in two inbred strains of guinea-pigs. Immunology 1967; 12: 573.
60. Katz DH, Davie JM, Paul WE, Benacerraf B. Carrier function in anti-hapten antibody responses. IV. Experimental conditions for the induction of hapten-specific tolerance or for the stimulation of anti-hapten anamnestic responses by "non-immunogenic" hapten-polypeptide conjugates. J Exp Med 1971; 134: 201.
61. Benkirane N, Friede M, Guichard G, Briand JP, Van Regenmortel MHV, Muller S. Antigenicity and immunogenicity of modified synthetic peptides containing D-amino acid residues: antibodies to a D-enantiomer do recognize the parent L-hexapeptide and reciprocally. J Biol Chem 1993; 268: 26279.
62. Dintzis HM, Symer DE, Dintzis RZ, Zawadzke LE, Berg JM. A comparison of the immunogenicity of a pair of enantiomeric proteins. Proteins 1993; 16: 306.
63. De L, Milton RC, Milton SCF, Kent SBH. Total chemical synthesis of a D-enzyme: the enantiomers of HIV-1 protease show demonstration of reciprocal chiral substrate specificity. Science 1992; 256: 1445.